References
- Almasri NM, Al Hamad M (2005). Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan. Breast Cancer Res,7,R598-604. https://doi.org/10.1186/bcr1200
- Aryandono T, Harijadi, Soeripto (2006). Hormone receptor status of operable breast cancers in Indonesia: correlation with other prognostic factors and survival. Asian Pac J Cancer Prev,7,321-4.
- Ayadi L, Khabir A, Amouri H, et al (2008). Correlation of HER- 2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma. World J Surg Oncol,6,112. https://doi.org/10.1186/1477-7819-6-112
- Azizun-Nisa, Bhurgri Y, Raza F, Kayani N (2008). Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer. Asian Pac J Cancer Prev,9,553-6.
- Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007). Descriptive analysis of Estrogen Receptor(ER)-Negative, Progesterone Receptor (PR)-Negative, and HER2-Negative Invasive Breast Cancer, the so-called Triple-Negative Phenotype. Cancer,109,1721-8. https://doi.org/10.1002/cncr.22618
- Choi DH, Shin DB, Lee MH, et al (2003). A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma. Cancer,98,1587-95. https://doi.org/10.1002/cncr.11703
- Gluz O, Liedtke C, Gottschalk N, et al (2009). Triple-negative breast cancer-current status and future directions. Ann Oncol,20,1913-27. https://doi.org/10.1093/annonc/mdp492
- Huang HJ, Neven P, Drijkoningen M, et al (2005). Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer. J Clin Pathol,58,611-6. https://doi.org/10.1136/jcp.2004.022772
- Iwase H, Kurebayashi J, Tsuda H,et al(2010). Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society. Breast Cancer, 17,118-24. https://doi.org/10.1007/s12282-009-0113-0
- James R, Thriveni K, Ramaswamy G,et al (2008). Evaluation of immunohistochemistry and enzyme linked immunosorbent assay for her-2/neu expression in breast carcinoma. Ind J Clin Biochemistry, 23 , 345-51. https://doi.org/10.1007/s12291-008-0076-5
- Kamil M, Yusuf N, Khalid I, et al (2010).Association between HER-2/neu over-expression and clinico-pathologic parameters of breast cancer in northern Malaysia. Ceylon Med J,55,9-13. https://doi.org/10.4038/cmj.v55i1.1701
- Kumar V, Tewari M, Singh U, Shukla HS (2007). Significance of Her-2/neu protein over expression in Indian breast cancer patients. Indian J Surg,69,122-28. https://doi.org/10.1007/s12262-007-0002-8
- Lal P, Tan LK, Chen B (2005). Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast carcinomas. Am J Clin Pathol,123,541-6. https://doi.org/10.1309/YMJ3A83TB39MRUT9
- Lund MJ, Butler EN, Bumpers HL, et al (2008).High prevalence of triple-negative tumors in an urban cancer center. Cancer,113,608-15. https://doi.org/10.1002/cncr.23569
- Lund MJ, Trivers KF, Porter PL,et al (2009). Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat,113,357-70. https://doi.org/10.1007/s10549-008-9926-3
- Munjal K, Ambaye A, Evans MF, et al (2009). Immunohistochemical analysis of ER, PR, Her2 and CK5/6 in Infiltrative Breast Carcinomas in Indian Patients. Asian Pac J Cancer Prev,10,773-8.
- Moore MA, Ariyaratne Y, Badar F,et al(2010) Cancer epidemiology in South Asia - past, present and future. Asian Pac J Cancer Prev,11 Suppl 2,49-66.
- Rhodes A, Jasani B, Balaton AJ, Barnes DM, Miller KD (2000). Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J Clin Pathol,53,688-96. https://doi.org/10.1136/jcp.53.9.688
- Ravdin PM, Cronin KA, Howlader N, et al (2007). The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med,356,1670-4. https://doi.org/10.1056/NEJMsr070105
- Saleh F, Abdeen S (2007). Pathobiological features of breast tumours in the State of Kuwait: a comprehensive analysis. J Carcinog,6,12. https://doi.org/10.1186/1477-3163-6-12
- Sandhu DS, Sandhu S, Karwasra RK, Marwah S (2010). Profile of breast cancer patients at a tertiary care hospital in north India. Indian J Cancer,47,16-22. https://doi.org/10.4103/0019-509X.58853
- Saxena S, Rekhi B, Bansal A, et al (2005). Clinico-morphological patterns of breast cancer including family history in a New Dehi hospital, India- a cross-sectional study. World J Surg Oncol ,3,67. https://doi.org/10.1186/1477-7819-3-67
- Shet T, Agrawal A, Nadkarni M, et al (2009). Hormone receptors over the last 8 years in a cancer referral center in India: what was and what is? Indian J Pathol Microbiol,52,171-4. https://doi.org/10.4103/0377-4929.48909
- Stead LA, Lash TL, Sobieraj JE, et al (2009). Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res,11,R18. https://doi.org/10.1186/bcr2242
- Taucher S, Rudas M, Mader RM, et al (2003). Do we need HER- 2/neu testing for all patients with primary breast carcinoma? Cancer,98,2547-53. https://doi.org/10.1002/cncr.11828
- Tischkowitz M, Brunet JS, Bégin LR, et al (2007). Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BMC Cancer,7,134. https://doi.org/10.1186/1471-2407-7-134
- Takiar R, Srivastav A (2008). Time trend in breast and cervix cancer of women in India - (1990-2003). Asian Pac J Cancer Prev, 9, 777-80.
- Vaidyanathan K, Kumar P, Reddy CO, et al(2010). ErbB- 2 expression and its association with other biological parameters of breast cancer among Indian women. Indian J Cancer,47,8-15. https://doi.org/10.4103/0019-509X.58852
- Vona-Davis L, Rose DP, Hazard H, et al (2008). Triple-negative breast cancer and obesity in a rural Appalachian population. Cancer Epidemiol Biomarkers Prev,17,3319-24 https://doi.org/10.1158/1055-9965.EPI-08-0544
- Yeole BB (2008). Trends in cancer incidence in female breast, cervix uteri, corpus uteri, and ovary in India. Asian Pacific J Cancer Prev, 9, 119-22.